Vanderbilt researcher named to 'dream team'

NASHVILLE, Tenn. (AP) -- A professor of medicine at the Vanderbilt-Ingram Cancer Center in Nashville has been named to a melanoma research "dream team."

According to a news release from the school, Jeffrey Sosman will work to write genomic-driven clinical trials and will lead one of several research sites that will enroll melanoma patients in such trials.

The trials are designed to identify molecular mutations that are unique to each patient's tumor and match the molecular characteristics to specific investigational drugs targeting these abnormalities.

Melanoma is the most dangerous type of skin cancer.

The "dream team" is supported by the organization Stand Up to Cancer and the Melanoma Research Alliance.

Join the Conversation!

To comment, the following rules must be followed:

  • No Obscenity, Profanity, Vulgarity, Racism or Violent Descriptions
  • No Negative Community Comparisons
  • No Fighting, Name-calling, or Personal Attacks
  • Multiple Accounts are Not Allowed
  • Stay on Story Topic

Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.

Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to Please provide detailed information.

powered by Disqus


6450 Papermill Drive Knoxville, TN 37919 Phone - (865) 450-8888; Fax - (865) 450-8869
Copyright © 2014 WVLT-TV Inc. - Designed by Gray Digital Media - Powered by Clickability 135733578 -
Gray Television, Inc.